华富中证港股通创新药指数型发起式A (024363.jj ) 港股通创新药 (半年) 华富基金管理有限公司申 | 基金经理郜哲基金类型指数型基金成立日期2025-06-06总资产规模 (2026-03-31) 基金净值1.0904元 (2026-05-11) 管理费用率0.50%管托费用率0.10% (2025-11-26) 成立以来分红再投入年化收益率9.04% (3119 / 5862) |
| 相关基金: | 主从基金: 华富中证港股通创新药指数型发起式C |
| 备注 (0): | 双击编辑备注 |
华富中证港股通创新药指数型发起式A(024363) - 基金对比
最后更新于：2026-05-11
非全收益率指数点位的计算不包含分红再投入，所以理论上指数基金的分红再投入收益率高于其对应的指数点位涨幅。
加载中......
| 日期 | 华富中证港股通创新药指数型发起式A - 相对起始点分红再投入收益率 | 港股通创新药 - 相对起始点收益率 |
|---|---|---|
| 2026-05-11 | 9.04% | 91.27% |
| 2026-05-08 | 8.93% | 90.99% |
| 2026-05-07 | 10.76% | 94.50% |
| 2026-05-06 | 8.95% | 90.95% |
| 2026-04-30 | 9.80% | 92.27% |
| 2026-04-29 | 9.66% | 92.09% |
| 2026-04-28 | 9.96% | 92.64% |
| 2026-04-27 | 9.75% | 92.11% |
| 2026-04-24 | 10.68% | 93.69% |
| 2026-04-23 | 10.01% | 92.53% |
| 2026-04-22 | 14.61% | 101.05% |
| 2026-04-21 | 15.41% | 102.70% |
| 2026-04-20 | 16.33% | 104.29% |
| 2026-04-17 | 17.40% | 106.13% |
| 2026-04-16 | 19.09% | 109.65% |
| 2026-04-15 | 18.10% | 107.98% |
| 2026-04-14 | 13.99% | 100.30% |
| 2026-04-13 | 13.23% | 98.58% |
| 2026-04-10 | 14.37% | 100.85% |
| 2026-04-09 | 13.56% | 99.29% |
| 2026-04-08 | 14.31% | 100.64% |
| 2026-04-07 | 16.27% | -- |
| 2026-04-03 | 16.39% | -- |
| 2026-04-02 | 16.30% | 103.74% |
| 2026-04-01 | 15.16% | 101.29% |
| 2026-03-31 | 7.94% | 87.73% |
| 2026-03-30 | 7.86% | 87.30% |
| 2026-03-27 | 7.54% | 86.87% |
| 2026-03-26 | 2.38% | 77.43% |
| 2026-03-25 | 3.91% | 80.83% |
| 2026-03-24 | 3.29% | 79.90% |
| 2026-03-23 | -0.53% | 72.63% |
| 2026-03-20 | 3.31% | 80.12% |
| 2026-03-19 | 4.81% | 82.69% |
| 2026-03-18 | 7.71% | 88.19% |
| 2026-03-17 | 6.15% | 85.06% |
| 2026-03-16 | 5.83% | 84.11% |
| 2026-03-13 | 3.18% | 79.29% |
| 2026-03-12 | 4.70% | 82.25% |
| 2026-03-11 | 6.66% | 86.05% |
| 2026-03-10 | 8.15% | 88.64% |
| 2026-03-09 | 4.94% | 82.14% |
| 2026-03-06 | 6.58% | 85.79% |
| 2026-03-05 | 2.45% | 78.24% |
| 2026-03-04 | 0.70% | 74.51% |
| 2026-03-03 | 3.03% | 79.20% |
| 2026-03-02 | 6.96% | 86.02% |
| 2026-02-27 | 10.54% | 92.82% |
| 2026-02-26 | 8.37% | 88.66% |
| 2026-02-25 | 13.88% | 98.61% |